Literature DB >> 18097958

Orbitotemporal neurofibromatosis: classification and treatment.

Melanie H Erb1, Nicolas Uzcategui, Robert F See, Michael A Burnstine.   

Abstract

PURPOSE: To review the clinical findings in orbitotemporal neurofibromatosis and discuss treatment options. Clinical features, histopathologic characteristics, and treatment options are reviewed.
METHODS: A Medline literature search from 1966 to 2004 was performed, using the key words: orbitotemporal neurofibromatosis, orbitopalpebral neurofibromatosis, orbitofacial neurofibromatosis, cranio-orbital neurofibromatosis, and cranio-orbital-temporal neurofibromatosis, and the pertinent literature was reviewed. Additionally, our experience with two patients is reported. The surgical procedures are discussed.
CONCLUSION: The management of orbitotemporal neurofibromatosis is challenging. The planned surgical approach and extent of resection depend on the severity of the orbital soft tissue and bony involvement and on the visual potential. Ultimately, orbital exenteration may be needed for rehabilitation and cosmesis.

Entities:  

Mesh:

Year:  2007        PMID: 18097958     DOI: 10.1080/01676830600987227

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  10 in total

Review 1.  Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.

Authors:  Robert A Avery; James A Katowitz; Michael J Fisher; Gena Heidary; Eva Dombi; Roger J Packer; Brigitte C Widemann
Journal:  Ophthalmology       Date:  2016-11-03       Impact factor: 12.079

2.  Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome.

Authors:  I A Chaudhry; J Morales; F A Shamsi; W Al-Rashed; E Elzaridi; Y O Arat; C Jacquemin; D T Oystreck; T M Bosley
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

3.  Transcranial surgery through pterional approach for removal of cranio-orbital tumors by an interdisciplinary team of nurosurgeons and ophthalmologists.

Authors:  Yan Liu; Jiang-Rong Ma; Xue-Liang Xu
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

4.  The Number of Surgical Interventions and Specialists Involved in the Management of Patients with Neurofibromatosis Type I: A 25-Year Analysis.

Authors:  Chih-Kai Hsu; Rafael Denadai; Chun-Shin Chang; Chuan-Fong Yao; Ying-An Chen; Pang-Yun Chou; Lun-Jou Lo; Yu-Ray Chen
Journal:  J Pers Med       Date:  2022-04-01

Review 5.  Ophthalmological assessment of children with neurofibromatosis type 1.

Authors:  Catherine Cassiman; Eric Legius; Werner Spileers; Ingele Casteels
Journal:  Eur J Pediatr       Date:  2013-05-25       Impact factor: 3.183

6.  Mechanical Ptosis in Neurofibromatosis Type 1 Heralding the Diagnosis of Right Sided Cervical Vagus Nerve Neurofibroma: A Rare Case Report.

Authors:  Jyotiranjan Mallick; Sucheta Parija; Bijnya Panda; Susanta Pujahari; Satyaswarup Jena
Journal:  J Clin Diagn Res       Date:  2016-06-01

7.  Orbitotemporal neurofibromatosis: case report.

Authors:  Mahalakshmi Balasubramanyam; Goutham Cugati; Bipasha Mukherjee
Journal:  Case Rep Ophthalmol Med       Date:  2012-03-29

8.  Plexiform Neurofibroma Involving the Lacrimal Gland.

Authors:  Mikael Hofsli; Nico Gampenrieder; Steffen Heegaard
Journal:  Case Rep Ophthalmol       Date:  2017-01-31

9.  Differential gene methylation and expression of HOX transcription factor family in orbitofacial neurofibroma.

Authors:  Antje Arnold; Eddie Luidy Imada; M Lisa Zhang; Deepak P Edward; Luigi Marchionni; Fausto J Rodriguez
Journal:  Acta Neuropathol Commun       Date:  2020-05-04       Impact factor: 7.801

10.  RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.

Authors:  Eddie Luidy Imada; Diego Strianese; Deepak P Edward; Rawan alThaqib; Antionette Price; Antje Arnold; Hailah Al-Hussain; Luigi Marchionni; Fausto J Rodriguez
Journal:  Brain Pathol       Date:  2021-07-23       Impact factor: 6.508

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.